| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |